Filing Details
- Accession Number:
- 0001127602-15-008869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-27 18:32:19
- Reporting Period:
- 2015-02-25
- Filing Date:
- 2015-02-27
- Accepted Time:
- 2015-02-27 18:32:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229873 | L Joseph Herring | 210 Carnegie Center Princeton NJ 08540 | Ceo Of Covance Drug Division | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-02-25 | 30,718 | $121.56 | 6,158 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-25 | 6,158 | $122.03 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Includes 17 shares that were excluded from the reporting person's Form 3 filed on February 25, 2015 due to a reporting software error.
- The price of $121.5568 per share represents a weighted average of sales prices ranging from $121.125 to $121.99 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $122.0279 per share represents a weighted average of sales prices ranging from $122.00 to $122.15 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
